1. Adjuvant Therapy: Finding the Right Approach for Your Patient with HER2-Positive Breast Cancer

2. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

3. Overview

4. Treatment

5. Case 1: Presentation

6. Case 1 (cont)

7. Case 1: Discussion

8. Case 1: Discussion (cont)

9. ExteNET Results

10. Case 2: Presentation

11. Case 2: Discussion

12. Updated Analysis of the APT Trial

13. Case 2: Discussion (cont)

14. What Does the Future Hold?

15. Conclusions

16. Abbreviations